Author:
Larsen Knud,Farajzadeh Leila,Kristensen Kaja Kjaer
Reference43 articles.
1. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes;Adkins;Am. J. Hum. Genet.,1993
2. Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease;Akhmedova;J. Neurol. Sci.,2001
3. Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis;Bayrak;J. Atheroscler. Thromb.,2012
4. Paraoxonases and infectious diseases;Camps;Clin. Biochem.,2017
5. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke;Can Demirdöğen;Clin. Biochem.,2008